These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 11170516

  • 1. Selenoxidation by flavin-containing monooxygenases as a novel pathway for beta-elimination of selenocysteine Se-conjugates.
    Rooseboom M, Commandeur JN, Floor GC, Rettie AE, Vermeulen NP.
    Chem Res Toxicol; 2001 Jan; 14(1):127-34. PubMed ID: 11170516
    [Abstract] [Full Text] [Related]

  • 2. Bioactivation of chemopreventive selenocysteine Se-conjugates and related amino acids by amino acid oxidases novel route of metabolism of selenoamino acids.
    Rooseboom M, Vermeulen NP, van Hemert N, Commandeur JN.
    Chem Res Toxicol; 2001 Aug; 14(8):996-1005. PubMed ID: 11511173
    [Abstract] [Full Text] [Related]

  • 3. Comparative study on the bioactivation mechanisms and cytotoxicity of Te-phenyl-L-tellurocysteine, Se-phenyl-L-selenocysteine, and S-phenyl-L-cysteine.
    Rooseboom M, Vermeulen NP, Durgut F, Commandeur JN.
    Chem Res Toxicol; 2002 Dec; 15(12):1610-8. PubMed ID: 12482244
    [Abstract] [Full Text] [Related]

  • 4. Tissue distribution of cytosolic beta-elimination reactions of selenocysteine Se-conjugates in rat and human.
    Rooseboom M, Vermeulen NP, Groot EJ, Commandeur JN.
    Chem Biol Interact; 2002 Aug 15; 140(3):243-64. PubMed ID: 12204580
    [Abstract] [Full Text] [Related]

  • 5. Oxidation of cysteine S-conjugates by rabbit liver microsomes and cDNA-expressed flavin-containing mono-oxygenases: studies with S-(1,2-dichlorovinyl)-L-cysteine, S-(1,2,2-trichlorovinyl)-L-cysteine, S-allyl-L-cysteine, and S-benzyl-L-cysteine.
    Ripp SL, Overby LH, Philpot RM, Elfarra AA.
    Mol Pharmacol; 1997 Mar 15; 51(3):507-15. PubMed ID: 9058607
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of the kinetics of beta-elimination reactions of selenocysteine Se-conjugates in human renal cytosol: possible implications for the use as kidney selective prodrugs.
    Rooseboom M, Vermeulen NP, Andreadou I, Commandeur JN.
    J Pharmacol Exp Ther; 2000 Aug 15; 294(2):762-9. PubMed ID: 10900258
    [Abstract] [Full Text] [Related]

  • 9. Studies on the inhibition of human cytochromes P450 by selenocysteine Se-conjugates.
    Venhorst J, Rooseboom M, Vermeulen NP, Commandeur JN.
    Xenobiotica; 2003 Jan 15; 33(1):57-72. PubMed ID: 12519694
    [Abstract] [Full Text] [Related]

  • 10. The imidazoacridinone antitumor drug, C-1311, is metabolized by flavin monooxygenases but not by cytochrome P450s.
    Potega A, Dabrowska E, Niemira M, Kot-Wasik A, Ronseaux S, Henderson CJ, Wolf CR, Mazerska Z.
    Drug Metab Dispos; 2011 Aug 15; 39(8):1423-32. PubMed ID: 21555506
    [Abstract] [Full Text] [Related]

  • 11. Sulfoxidation of cysteine and mercapturic acid conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A).
    Altuntas TG, Park SB, Kharasch ED.
    Chem Res Toxicol; 2004 Mar 15; 17(3):435-45. PubMed ID: 15025515
    [Abstract] [Full Text] [Related]

  • 12. Cyclic conversion of the novel Src kinase inhibitor [7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-oxide metabolite by flavin-containing monoxygenases and cytochrome P450 reductase.
    Kousba A, Soll R, Yee S, Martin M.
    Drug Metab Dispos; 2007 Dec 15; 35(12):2242-51. PubMed ID: 17881660
    [Abstract] [Full Text] [Related]

  • 13. S-(1,2,2-trichlorovinyl)-L-cysteine sulfoxide, a reactive metabolite of S-(1,2,2-Trichlorovinyl)-L-cysteine formed in rat liver and kidney microsomes, is a potent nephrotoxicant.
    Elfarra AA, Krause RJ.
    J Pharmacol Exp Ther; 2007 Jun 15; 321(3):1095-101. PubMed ID: 17347324
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases. Comparison of human liver and kidney microsomes and mammalian enzymes.
    Hamman MA, Haehner-Daniels BD, Wrighton SA, Rettie AE, Hall SD.
    Biochem Pharmacol; 2000 Jul 01; 60(1):7-17. PubMed ID: 10807940
    [Abstract] [Full Text] [Related]

  • 18. Methionine S-oxidation in human and rabbit liver microsomes: evidence for a high-affinity methionine S-oxidase activity that is distinct from flavin-containing monooxygenase 3.
    Ripp SL, Itagaki K, Philpot RM, Elfarra AA.
    Arch Biochem Biophys; 1999 Jul 15; 367(2):322-32. PubMed ID: 10395751
    [Abstract] [Full Text] [Related]

  • 19. In vitro metabolism of clindamycin in human liver and intestinal microsomes.
    Wynalda MA, Hutzler JM, Koets MD, Podoll T, Wienkers LC.
    Drug Metab Dispos; 2003 Jul 15; 31(7):878-87. PubMed ID: 12814964
    [Abstract] [Full Text] [Related]

  • 20. Comparative cytotoxicity of 14 novel selenocysteine se-conjugates in rat renal proximal tubular cells.
    Andreadou I, van de Water B, Commandeur JN, Nagelkerke FJ, Vermeulen NP.
    Toxicol Appl Pharmacol; 1996 Nov 15; 141(1):278-87. PubMed ID: 8917701
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.